PRE – prenetics global limited - class a ordinary share (US:NASDAQ)
Stock Stats
News
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers [Seeking Alpha]
Prenetics Global Limited (NASDAQ: PRE) had its price target lowered by analysts at Cantor Fitzgerald from $10.00 to $9.00. They now have an "overweight" rating on the stock.
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
Form 20-F Prenetics Global Ltd For: Dec 31
Form S-8 Prenetics Global Ltd
Form 6-K Prenetics Global Ltd For: Apr 01
Form EFFECT Prenetics Global Ltd
Form 424B3 Prenetics Global Ltd
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.